Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Новые технологии в контрацепции: гормональные рилизинг-системы
Новые технологии в контрацепции: гормональные рилизинг-системы
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Внутриматочная контрацепция (руководство) под ред. проф. Прилепской В.Н. 2000; с. 153–78.
2. Zieman M, Guillebaud J, Weisberg E et al. Contraceptive eficacy and cycle control with the Ortho evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002; 77 (Suppl. 2): S13–S18.
3. Archer D, Bigrigg A, Smallwood G et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American Women. Fertil Steril 2002; 77 (Suppl. 2): S27–S31.
4. Smallwood G, meador M, Lenihan JrJ et al. For the ORTHO EVRA/EVRA002 Study Group. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001; 98: 799–805.
5. Audet M-C, Moreau M, Koltun W et al. For the ORTHO EVRA/EVRA004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive. JAMA 2001; 285: 2347–54,
6. Archer D, Bigrigg A, Smallwood G et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American Women. Fertil Steril 2002; 77 (Suppl. 2): S27–S31.
7. Smallwood G, Meador M, Lenihan JrJ et al. For the ORTHO EVRA/EVRA002 Stady Group. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001; 98: 799–805.
8. Audet M-C, Moreau M, Koltun W et al. For the ORTHO EVRA/EVRA004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive. JAMA 2001; 285: 2347–54.
9. Abrams L, Skee D, Natarajan J et al. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinylestradiol at four application sites. Br J clin Pharmacol 2002b; 53: 141–6.
2. Zieman M, Guillebaud J, Weisberg E et al. Contraceptive eficacy and cycle control with the Ortho evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002; 77 (Suppl. 2): S13–S18.
3. Archer D, Bigrigg A, Smallwood G et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American Women. Fertil Steril 2002; 77 (Suppl. 2): S27–S31.
4. Smallwood G, meador M, Lenihan JrJ et al. For the ORTHO EVRA/EVRA002 Study Group. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001; 98: 799–805.
5. Audet M-C, Moreau M, Koltun W et al. For the ORTHO EVRA/EVRA004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive. JAMA 2001; 285: 2347–54,
6. Archer D, Bigrigg A, Smallwood G et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American Women. Fertil Steril 2002; 77 (Suppl. 2): S27–S31.
7. Smallwood G, Meador M, Lenihan JrJ et al. For the ORTHO EVRA/EVRA002 Stady Group. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001; 98: 799–805.
8. Audet M-C, Moreau M, Koltun W et al. For the ORTHO EVRA/EVRA004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive. JAMA 2001; 285: 2347–54.
9. Abrams L, Skee D, Natarajan J et al. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinylestradiol at four application sites. Br J clin Pharmacol 2002b; 53: 141–6.
Авторы
В.Н.Прилепская, Н.М.Назаров
ГУ Научный центр акушерства, гинекологии и перинатологии
(дир. – акад. РАМН В.И.Кулаков) РАМН, Москва
ГУ Научный центр акушерства, гинекологии и перинатологии
(дир. – акад. РАМН В.И.Кулаков) РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.